Apicore

Executive Summary

Apicore LLC is a US-based contract research and manufacturing organization (CRAMO) specializing in the development and production of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. Founded in 2003 and headquartered in Somerset, New Jersey, the company provides end-to-end services from research and process development to commercial-scale cGMP manufacturing for the generic and specialty pharmaceutical industries. As a privately held company, Apicore focuses on supporting its clients through the entire drug development lifecycle, leveraging its expertise in complex API synthesis and regulatory compliance. The company's strategic position in the growing generic API market, combined with its technical capabilities, positions it for potential growth driven by increased demand for cost-effective pharmaceutical manufacturing solutions. However, due to its private nature, financial details are limited, and its performance is closely tied to its client engagements and regulatory outcomes.

Upcoming Catalysts (preview)

• Q3 2026FDA approval of new generic API from a key client60% success
• Q4 2026Expansion of manufacturing capacity or new facility announcement50% success
• Q1 2027Strategic partnership or long-term supply agreement with a major pharmaceutical company40% success